Choong D - Search Results

1

No germline mutations in the histone acetyltransferase gene EP300 in BRCA1 and BRCA2 negative families with breast cancer and gastric, pancreatic, or colorectal cancer.

Campbell IG, Choong D, Chenevix-Trench G; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer. Campbell IG, et al. Among authors: choong d. Breast Cancer Res. 2004;6(4):R366-71. doi: 10.1186/bcr803. Epub 2004 May 14. Breast Cancer Res. 2004. PMID: 15217503 Free PMC article.

2

Genetic and epigenetic analysis of CHEK2 in sporadic breast, colon, and ovarian cancers.

Williams LH, Choong D, Johnson SA, Campbell IG. Williams LH, et al. Among authors: choong d. Clin Cancer Res. 2006 Dec 1;12(23):6967-72. doi: 10.1158/1078-0432.CCR-06-1770. Clin Cancer Res. 2006. PMID: 17145815

3

Mutation analysis of EP300 in colon, breast and ovarian carcinomas.

Bryan EJ, Jokubaitis VJ, Chamberlain NL, Baxter SW, Dawson E, Choong DY, Campbell IG. Bryan EJ, et al. Int J Cancer. 2002 Nov 10;102(2):137-41. doi: 10.1002/ijc.10682. Int J Cancer. 2002. PMID: 12385008 Free article.

4

Mutation of the PIK3CA gene in ovarian and breast cancer.

Campbell IG, Russell SE, Choong DY, Montgomery KG, Ciavarella ML, Hooi CS, Cristiano BE, Pearson RB, Phillips WA. Campbell IG, et al. Cancer Res. 2004 Nov 1;64(21):7678-81. doi: 10.1158/0008-5472.CAN-04-2933. Cancer Res. 2004. PMID: 15520168

5

No association of the MDM2 SNP309 polymorphism with risk of breast or ovarian cancer.

Campbell IG, Eccles DM, Choong DY. Campbell IG, et al. Cancer Lett. 2006 Aug 28;240(2):195-7. doi: 10.1016/j.canlet.2005.09.003. Epub 2005 Oct 18. Cancer Lett. 2006. PMID: 16239061

6

Genetic and epigenetic analysis of the putative tumor suppressor km23 in primary ovarian, breast, and colorectal cancers.

Campbell IG, Phillips WA, Choong DY. Campbell IG, et al. Clin Cancer Res. 2006 Jun 15;12(12):3713-5. doi: 10.1158/1078-0432.CCR-06-0800. Clin Cancer Res. 2006. PMID: 16778097

7

BARD1 variants are not associated with breast cancer risk in Australian familial breast cancer.

Gorringe KL, Choong DY, Visvader JE, Lindeman GJ, Campbell IG. Gorringe KL, et al. Breast Cancer Res Treat. 2008 Oct;111(3):505-9. doi: 10.1007/s10549-007-9799-x. Epub 2007 Oct 31. Breast Cancer Res Treat. 2008. PMID: 17972171

8

Breast cancer risk and the BRCA1 interacting protein CTIP.

Gorringe KL, Choong DY, Lindeman GJ, Visvader JE, Campbell IG. Gorringe KL, et al. Breast Cancer Res Treat. 2008 Nov;112(2):351-2. doi: 10.1007/s10549-007-9862-7. Epub 2007 Dec 20. Breast Cancer Res Treat. 2008. PMID: 18095152

9

Frequent somatic mutations of GATA3 in non-BRCA1/BRCA2 familial breast tumors, but not in BRCA1-, BRCA2- or sporadic breast tumors.

Arnold JM, Choong DY, Thompson ER; kConFab; Waddell N, Lindeman GJ, Visvader JE, Campbell IG, Chenevix-Trench G. Arnold JM, et al. Breast Cancer Res Treat. 2010 Jan;119(2):491-6. doi: 10.1007/s10549-008-0269-x. Epub 2009 Feb 3. Breast Cancer Res Treat. 2010. PMID: 19189213

10

Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients.

Thompson ER, Boyle SE, Johnson J, Ryland GL, Sawyer S, Choong DY, kConFab, Chenevix-Trench G, Trainer AH, Lindeman GJ, Mitchell G, James PA, Campbell IG. Thompson ER, et al. Hum Mutat. 2012 Jan;33(1):95-9. doi: 10.1002/humu.21625. Epub 2011 Nov 4. Hum Mutat. 2012. PMID: 21990120 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page